Biodexa Pharmaceuticals Plc
November 27, 2023 at 12:49 pm - by Joey Ramson
$BDRX is up over 100% and the leader of the Nasdaq after the company entered an agreement to acquire Adhera Therapeutics’s rights to tolimidone, a potential diabetes treatment
